Current Perspectives in Ultra-Sensitive Detection of Cancer-Specific Biomarkers and Therapeutic Targets

Savvateeva, L.V.; Zernii, E.Y.; Zamyatnin, A.A.

Авторы: Savvateeva Lyudmila V., Zernii Evgeni Yu, Zamyatnin Andrey A.
Журнал: Current Cancer Drug Targets
Том: 23
Номер: 11
Год издания: 2023
Издательство: Bentham Science Publishers
Местоположение издательства: Netherlands
Первая страница: 829
Последняя страница: 833
DOI: 10.2174/1568009623666230420152113
Аннотация: As a rapidly-evolving area of scientific research with undeniable significance to public health, the early detection of disease for favorable prognostic outcomes has taken on greater importance. Herein, we describe how such a detection paradigm takes aim at how cancer-retina antigens have the potential to be detected with greater accuracy through their isolation and ultra-sensitive detection as novel biomarkers and potential targets. However, the detection limitations of this approach are defined by the detection of nanogram quantities of antigen, thus highlighting a novel requirement for sensitive assays with enhanced specificity and reproducibility. Indeed, this technology can potentially enable the monitoring of antigen levels at earlier stages of cancer progression, as well as during treatment and remission. However, the applicability of this method may be significantly limited by the high cost of dyes, the need for a fluorimeter, as well as the purity of the T7 RNA polymerase. In summary, the detection and utilization of novel biomarkers and potential therapeutic targets with technological advances have co-evolved with some very encouraging findings, most notably in precision medicine.
Добавил в систему: Зерний Евгений Юрьевич

	ИСТИНА	Войти в систему Регистрация
	ИСТИНА ЦЭМИ РАН
	Главная Поиск Статистика О проекте Помощь

ИСТИНА

ИСТИНА ЦЭМИ РАН

Current Perspectives in Ultra-Sensitive Detection of Cancer-Specific Biomarkers and Therapeutic Targetsстатья

Прикрепленные файлы